Skip to main content
Fig. 1 | BMC Rheumatology

Fig. 1

From: Circulating exo-miRNA-27a-5p is a novel biomarker of the tofacitinib treatment response in rheumatoid arthritis

Fig. 1

Identification of circulating exosomes. (a, b) Size and concentration of circulating exosomes from patients with rheumatoid arthritis (RA) and healthy controls (HCs) analyzed by nanoparticle tracking analysis (NTA), respectively; (c, d) Circulating exosomes of patients with RA and HCs verified by transmission electron microscopy (TEM), respectively; scale bar: 200 nm. (e) Specific exosome markers CD9, CD63 and HSP70 analyzed by Western blotting

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us